Abstract
The authors present current theory of the aetiology and pathogenesis of Kawasaki disease with special reference to clinical presentation and cardiac complications. Current therapeutic management has also been discussed.
MeSH terms
-
Aspirin / therapeutic use
-
Cardiovascular Diseases / etiology
-
Child, Preschool
-
Female
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use
-
Infant
-
Male
-
Mucocutaneous Lymph Node Syndrome / complications
-
Mucocutaneous Lymph Node Syndrome / diagnosis
-
Mucocutaneous Lymph Node Syndrome / drug therapy
-
Mucocutaneous Lymph Node Syndrome / etiology*
-
Prognosis
Substances
-
Immunoglobulins, Intravenous
-
Aspirin